<<

THE LITERATURE LIST

1. Clinical rheumatology (a management for doctors) / I.B.Beljaeva, E.G.Zotkin, N.A.Kunitsky, etc. [under the editorship of V.I.Mazurova]. - SPb., 2005. - 514 with.

2. Nasonov, E.L.immunopatholog of a pseudorheumatism and an osteoporosis: new data / E.L.Nasonov, D.A.Gukasjan, M.B.Nasonov//the Osteoporosis and osteopathies.

- 2000. - №2. - with. 4-7.

3. Nasonov, E.L.new aspects of application of cyclosporine And (Sandimmun) in rheumatology: treatment of a system lupus erythematosus / E.L.Nasonov, N.G.Kljukvina, S.V.Shekshina, V.A.Nasonov//Therapeutic archive. - 2000. - № 5. - with. 67-71.

4. Nasonov, E.L.antiinflammator therapy of rheumatic illnesses / E.L.Nasonov. - M, 1996. - 520 with.

5. Pauls, A.D.erythrogenes, erythropoetin, iron. Molecular and clinical aspects / A.D.Paul, E.F.Morshchakova, A.G.Rumjantsev. - M, 2011. - 304 with.

6. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative / D. Aletaha, T. Neogi, A.J. Silman et al. / Arthritis Rheum. - 2010. - 62 (9). - THE RIVER 2569-2581.

7. A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression / D.L. Zhang, R.M. Hughes, H. Ollivierre-Wilson et al.//Cell Metab. - 2009. - № 9. - THE RIVER 461-473.

8. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokinereceptor signalling: contribution of SHP-1 C-terminal tyrosines in cytokine signalling / P. Minoo, M.M. Zadeh, R. Rottapel et al.//Blood. - 2004. - №103. - THE RIVER 1398-1407.

9. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression / R.H. Wang, C. Li X. Xu et al.//Cell Metab. - 2005. - №2. - THE RIVER 399-409.

10. Abnormalities in circulating plasmacytoid dendritic cells in patients with systemic lupus erythematosus / O. Jin, S. Kavikondala, M.Y. Mok et al.//Arthritis Research AND Therapy. - 2010. - Vol.12, №4. - R R137.

11. Adams, A. Update on the pathogenesis and treatment of systemic onset juvenile rheumatoid arthritis / A. Adams, T.J. Lehman//Curr Opin Rheumatol. - 2005. - №17. - P. 612-616.

12. Andrews, N.C. Anemia of inflammation: the cytokine-hepcidin link / N.C. Andrews//J Clin Invest. - 2004. - 113 (9). - THE RIVER 1251-1253.

13. Andrews, N.C. The iron transporter DMT1 / N.C. Andrews//Int J Biochem Cell Biol. - 1999. - №31. - THE RIVER 991-994.

14. Anemia and blood transfusion in critically ill patients / J.L. Vincent, J.F. Baron,

K. Reinhart et al.//JAMA. - 2002. - №288. - THE RIVER 1499-1507.

15. Anti-citrullinated protein antibody (ACPA) in rheumatoid arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione S-transferase in a cross-sectional study / T.R. Mikuls, K.A. Gould,

K.K. Bynote, et al.//Arthritis Res Ther. - 2010. - №12. - R R213.

16. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFa, anti-IL-1a/e, and IL-1Ra / L.A.B. Joosten, M.M.A. Helsen, F.A.J. van de Loo, W.B. van den Berg//Arthritis Rheum. - 1996. - №39. - THE RIVER 797-809.

17. Association between serum inflammatory cytokines and disease activity in juvenile idiopathic arthritis / L.S.

Ou, L.C. See, C.J. Wu et al.//Clin Rheumatol. - 2002. - №21. - THE RIVER 52-56.

18. Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in an UK population: further support that PTPN22 is an autoimmunity gene / A. Hinks, A. Barton, S. John et al.//Arthritis Rheum. -

2005. - №52. - THE RIVER 1694-1699.

19. Association of anaemia and physical disability among patients with rheumatoid arthritis / C. Han, M.U. Rahman, M.K. Doyle et al.//J Rheumatol. - 2007. - 34 (11). - THE RIVER 2177-2182.

20. Association of antigen specificity and migratory capacity of memory T cells in rheumatoid arthritis / K.R. Shadidi, K.M. Thompson, J.E. Henriksen et al.//Scand J Immunol. - 2002. - №55. - THE RIVER 274-283.

21. Association of HLA-B27 genetic polymorphisms with ankylosing spondylitis susceptibility worldwide: a meta-analysis / T. Yang, Z. Duan, S. Wu et al.//Mod Rheumatol. - 2014. - 24 (1). - THE RIVER 150-161.

22. Autologous stem cell transplantation for autoimmunity induces immunologic selftolerance by reprogramming autoreactive T cells and restoring the CD4+CD25 + immune regulatory network I. De Kleer, B. Vastert, M. Klein et al.//Blood. -

2006. - №107. - THE RIVER 1696-1702.

23. Barosi, G. Inadequate erythropoietin response to anaemia: definition and clinical relevance / G. Barosi//Ann Hematol. - 1994. - №68. - THE RIVER 215-223.

24. Bijlsma, J.W. Methotrexate: still the anchor drug in RA treatment / J.W. Bijlsma,

J.W. Jacobs//Joint Bone Spine. - 2009. - №76. - THE RIVER 452-454.

25. Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcome /

L. S. Knudsen, M. Klarlund, H. Sk^dt et al.//J Rheumatol. - 2008. - №35. - THE RIVER 1277-1287.

26. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study / W. De Jager, E.P. Hoppenreijs, N.M. Wulffraat et al.//Ann Rheum Dis. - 2007. - №66. - THE RIVER 589-598.

27. Body iron stores and the risk of cancer / R.G. Stevens, D.Y. Jones, M.S. Micozzi, P.R. Taylor//N Engl J Med. - 1988. - №319. - THE RIVER 1047-1052.

28. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women / R. Jiang, J.E. Manson, J.B. Meigs et al.//JAMA. - 2004. - №291. - THE RIVER 711717.

29. Boros, C. Juvenile idiopathic arthritis / C. Boros, B. Whitehead//Aust Fam Physician. 2010 39 (9). THE RIVER 630-636.

30. Brugnara, C. Iron deficiency and erythropoiesis: new diagnostic approaches / C. Brugnara//Clin Chem. - 2003. - №49. - THE RIVER 1573-1578.

31. Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anaemia in vivo / L.L. Moldawer, M.A. Marano, H. Wei et al.//FASEB J. - 1989. - №3. - THE RIVER 1637-1643.

32. Camaschella, C. BMP6 orchestrates iron metabolism / C. Camaschella//Nat Genet. - 2009. - №41. - THE RIVER 386-388.

33. Camaschella, C. Iron and hepcidin: a story of recycling and balance / C. Camaschella//Hematology Am Soc Hematol Educ Program. - 2013. - THE RIVER 1-8.

34. Cartwright, G.E. The anaemia of chronic disorders / G.E. Cartwright, G.R. Lee//Br. J. Haematol. - 1971. - №21. - THE RIVER 147-152.

35. Cartwright, G.E. The anaemia of chronic disorders / G.E. Cartwright//Semin. Hematol. - 1966. - №3. - THE RIVER 351-375.

36. Cartwright, G.E. The anaemia of infection XVII. A review / G.E. Cartwright,

M.M. Wintrobe//Adv. Intern. Med. - 1952. - №5. - THE RIVER 165-226.

37. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis / I.M. De Kleer,

L. R. Wedderburn, L.S. Taams et al.//J Immunol. - 2004. - №172. - THE RIVER 64356443.

38. Coexpression of CD25 and CD27 identifies FoxP3 + regulatory T cells in inflamed synovia / C.R. Ruprecht, M. Gattorno, F. Ferlito et al.//J Exp Med. -

2005. - №201. - THE RIVER 1793-1803.

39. Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis / M. Chabaud, P. Garnero, J.M. Dayer et al.//Cytokine. - 2000. - №12. - THE RIVER 1092-1099.

40. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis / F. De Benedetti, M. Massa, P. Robbioni et al.//Arthritis Rheum. - 1991. - №34. - THE RIVER 1158-1163.

41. Cullis, J.O. Anaemia of chronic disease / J.O. Cullis//Clin Med. - 2013. - 13 (2). - THE RIVER 193-196.

42. Cullis, J.O. Diagnosis and management of anaemia of chronic disease: current status / J.O. Cullis//Br J Haematol. - 2011. - 154 (3). - THE RIVER 289-300.

43. Cytokine-mediated regulation of iron transport in human monocytic cells / S. Ludwiczek, E. Aigner I. Theurl, G. Weiss//Blood. - 2003. - №101. - THE RIVER 41484154.

44. Dallalio, G. Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations / G. Dallalio, E. Law, R.T. Jr. Means//Blood. -

2006. - 107 (7). - THE RIVER 2702-2704.

45. Decrease of interleukin 6 during the first 12 months is a prognostic marker for clinical outcome during 36 months treatment with disease-modifying
antirheumatic drugs / R.H. Straub, U. Muller-Ladner, T. Lichtinger et al.//Br J Rheumatol. - 1997. - №36. - THE RIVER 1298-1303.

46. Decreased erythropoietin response in patients with the anaemia of cancer / C.B. Miller, R.J. Jones, S. Piantadosi et al.//N Engl J Med. - 1990. - №322. - THE RIVER 1689-1692.

47. Defective iron supply to erythropoiesis and adequate endogenous erythropoietin production in the anaemia associated with systemic-onset juvenile chronic arthritis / M. Cazzola, L. Ponchio, F. De Benedetti et al.//Blood. - 1996. - №87. - THE RIVER 4824-4830.

48. Diagnostic potential of hepcidin testing in pediatrics / G. Cangemi, A. Pistorio,

M. Miano et al.//Eur J Haematol. - 2013. - 90 (4). - THE RIVER 323-330.

49. Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis / F. De Benedetti, P. Pignatti V. Gerloni et al.//J Rheumatol. - 1997. - №24. - THE RIVER 1403-1409.

50. Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate / R.N. Maini, P.C. Taylor, J. Szechinski et al.//Arthritis Rheum. - 2006. - №54. - THE RIVER 2817-2829.

51. Early activation of cutaneous vessels and epithelial cells is characteristic of acute systemic onset juvenile idiopathic arthritis / M. Frosch, D. Metze, D. Foell et al.//Exp Dermatol. - 2005. - №14. - THE RIVER 259-265.

52. Ebringer, A. HLA molecules, bacteria and autoimmunity / A. Ebringer, C. Wilson//J Med Microbiol. - 2000. - 49 (4). - THE RIVER 305-311.

53. Effect of hepcidin on intestinal iron absorption in mice / A.H. Laftah, B. Ramesh, R.J. Simpson et al.//Blood. - 2004. - №103. - THE RIVER 3940-3944.

54. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial / J.S. Smolen, A. Beaulieu, A. Rubbert-Roth et al.//Lancet. - 2008. - №371. - THE RIVER 987-997.

55. Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin / G. Weiss, E. Meusburger, G. Radacher et al.//Kidney Int. - 2003. - №64. - THE RIVER 572-578.

56. Effect of recombinant human erythropoietin and intravenous iron on anaemia and disease activity in rheumatoid arthritis / J.P. Kaltwasser, U. Kessler, R. Gottschalk et al.//J Rheumatol. - 2001. - №28. - THE RIVER 2430-2436.

57. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus / C.K. Wong, C.Y. Ho, E.K. Li, C.W. Lam//Lupus. - 2000. - №9. - THE RIVER 589-593.

58. Endocrinopathies in transfusion-associated iron overload / M.K. Kim, J.W. Lee,

K.H. Baek et al.//Clin Endocrinol (Oxf). - 2013. - 78 (2). - THE RIVER 271-277.

59. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukaemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines / M. Chabaud, F. Fossiez, J.L. Taupin, P. Miossec//J Immunol. - 1998. - №161. - THE RIVER 409-414.

60. Enns, C.A. Neogenin interacts with matriptase-2 to facilitate hemojuvelin cleavage / C.A. Enns, R. Ahmed, A.S. Zhang//J Biol Chem. - 2012. - 287 (42). - THE RIVER 35104-35117.

61. Expression of angiogenic factors in juvenile rheumatoid arthritis: correlation with revascularization of human synovium engrafted into SCID mice / M.P. Scola, T. Imagawa, G.P. Boivin et al.//Arthritis Rheum. - 2001. - №44. - THE RIVER 794-801.

62. Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis / M. Frosch, T. Vogl, S. Seeliger et al.//Arthritis Rheum. - 2003. - №48. - THE RIVER 2622-2626.

63. Factors influencing quality of life (QOL) for Korean patients with rheumatoid arthritis (RA) / S.K. Cho, D. Kim, J.B. Jun et al.//Rheumatol Int. - 2013. - 33 (1). - THE RIVER 93-102.

64. Firestein, G.S. Quantitative analysis of cytokine gene expression in rheumatoid arthritis / G.S. Firestein, J.M. Alvaro-Gracia, R. Maki//J Immunol. - 1990. - №144. - THE RIVER 3347-3353.

65. Foell, D. Proinflammatory S100 proteins in arthritis and autoimmune disease / D. Foell, J. Roth//Arthritis Rheum. - 2004. - №50. - THE RIVER 3762-3771.

66. Forre, O. Genetic epidemiology of juvenile idiopathic arthritis / O. Forre, A. Smerdel//Scand J Rheumatol. 2002 №31. THE RIVER 123-128.

67. FOXP3 + regulatory T cells in the human immune system / S. Sakaguchi, M. Miyara, C.M. Costantino, D.A. Hafler//Nat Rev Immunol. - 2010. - 10 (7). - THE RIVER 490-500.

68. Friend of GATA and GATA-6 modulate the transcriptional up-regulation of hepcidin in hepatocytes during inflammation / E.T. Bagu, A. Layoun, A. Calve, M.M. Santos//Biometals. - 2013. - 26 (6). - THE RIVER 1051-1065.

69. Frost, A.E. Anemia and erythropoietin levels in recipients of solid organ transplants / A.E. Frost, C.A. Keller//Transplantation. - 1993. - №56. - THE RIVER 1008-1011.

70. Fung, E. Manipulation of the hepcidin pathway for therapeutic purposes / E. Fung, E. Nemeth//Haematologica. - 2013. - 98 (11). - THE RIVER 1667-1676.

71. Ganz, T. Hepcidin - a regulator of intestinal iron absorption and iron recycling by macrophages / T. Ganz//Best Pract Res Clin Haematol. - 2005. - 18 (2). - THE RIVER 171-182.

72. Ganz, T. The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders / T. Ganz, E. Nemeth//Hematology Am Soc Hematol Educ Program. - 2011. - №2011. - THE RIVER 538-542.

73. Ganz, T. Hepcidin and iron homeostasis / T. Ganz, E. Nemeth//Biochim Biophys Acta. - 2012. - 1823 (9). - THE RIVER 1434-43.

74. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci / E.A. Stahl, S. Raychaudhuri, E.F. Remmers et al.//Nat Genet. - 2010. - №42. - THE RIVER 508-514.

75. Genome-wide association study of genetic predictors of anti-tumour necrosis factor (TNF) treatment in rheumatoid arthritis (RA) identifies associations with polymorphisms at seven loci / D. Plant, J. Bowes, C. Potter et al.//Arthritis Rheum. - 2010. - №63. - THE RIVER 645-653.

76. Gizinski, A.M. T cell subsets and their role in the pathogenesis of rheumatic disease / A.M. Gizinski, D.A. Fox//Curr Opin Rheumatol. - 2014. - 26 (2). - THE RIVER 204-210.

77. Global prevalence of ankylosing spondylitis / L.E. Dean, G.T. Jones, A.G. Macdonald et al.//Rheumatology (Oxford). - 2013. - Dec 9. - 10 p.

78. Goodnough, L.T. Anemia, transfusion, and mortality / L.T. Goodnough, R.G. Bach//N Engl J Med. - 2001. - №345. - THE RIVER 1272-1274.

79. Goodnough, L.T. Erythropoietin, iron, and erythropoiesis / L.T. Goodnough, B. Skikne, C. Brugnara//Blood. - 2000. - №96. - THE RIVER 823-833.

80. Goswami, T. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron
sensing / T. Goswami, N.C. Andrews//J Biol Chem. - 2006. - №281. - THE RIVER 28494-28498.

81. Grom, A.A. Macrophage activation syndrome: advances towards understanding pathogenesis / A.A. Grom, E.D. Mellins//Curr Opin Rheumatol. - 2010. - 22 (5). - THE RIVER 561-566.

82. Guidi, G.C. Advancements in anemias related to chronic conditions / G.C. Guidi, C. Lechi Santonastaso//Clin Chem Lab Med. - 2010. - 48 (9). - THE RIVER 12171226.

83. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System//World Health Organization, Geneva. - 2011. - URL: http://www.who.int/vmnis/indicators/haemoglobin.pdf

84. Hagve, T.A. Iron deficiency anaemia - interpretation of biochemical and haematological findings / T.A. Hagve, K. Lilleholt, M. Svendsen//Tidsskr Nor Laegeforen. - 2013. - 133 (2). - THE RIVER 161-164.

85. Hahn, Y.S. Pathogenesis and clinical manifestations of juvenile rheumatoid arthritis / Y.S. Hahn, J.G. Kim//Korean J Pediatr. - 2010. - 53 (11). - THE RIVER 921930.

86. Hashimoto, M. Role of Th17 cells and innate immunnity for the induction of autoimmune arthritis / M. Hashimoto, T. Mimori//Nihon Rinsho Meneki Gakkai Kaishi. - 2012. - 35 (6). - THE RIVER 463-469.

87. Heinrich, P.C. Interleukin-6 and the acute phase response / P.C. Heinrich, J.V. Castell, T. Andus//Biochem J. - 1990. - №265. - THE RIVER 621-636.

88. Henry, D. Prediction of response to recombinant human erythropoietin (R - HuEPO/epoetin-alpha) therapy in cancer patients / D. Henry, R. Abels, K. Larholt//Blood. - 1995. - №85. - THE RIVER 1676-1678.

89. Hepatic acute phase proteins - regulation by IL-6 and IL-1-type cytokines involving STAT3 and its crosstalk with NF-KB-dependent signalling / J.G. Bode, U. Albrecht, D. Haussinger et al.//Eur J Cell Biol. - 2012. - 91 (6-7). - THE RIVER 496-505.

90. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein / T. Furutani, K. Hino, M. Okuda et al.//Gastroenterology. - 2006. - 130 (7). - THE RIVER 2087-2098.

91. Hepcidin and HFE protein: Iron metabolism as a target for the anaemia of chronic kidney disease / E. Canavesi, C. Alfieri, S. Pelusi, L. Valenti//World J Nephrol. - 2012. - 1 (6). - THE RIVER 166-176.

92. Hepcidin induction by pathogens and pathogen-derived molecules is strongly dependent on interleukin-6 / R. Rodriguez, C.L. Jung V. Gabayan et al.//Infect Immun. - 2014. - 82 (2). - THE RIVER 745-752.

93. Hepcidin production in response to iron is controlled by monocyte-derived humoral factors / Y. Sasaki, Y. Shimonaka, K. Ikuta et al.//Int J Hematol. - 2014. - 99 (1). - THE RIVER 12-20.

94. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization / E. Nemeth, M.S. Tuttle, J. Powelson et al.//Science. - 2004. - №306. - THE RIVER 2090-2093.

95. Hepcidin regulation by innate immune and infectious stimuli / A.E. Armitage,

L. A. Eddowes, U. Gileadi et al.//Blood. - 2011. - 118 (15). - THE RIVER 4129-4139.

96. Hepcidin, a putative mediator of anaemia of inflammation, is a type II acute-phase protein / E. Nemeth, E.V. Valore, M. Territo et al.//Blood. - 2003. - №101. - THE RIVER 2461-2463.

97. Hepcidin, an urinary antimicrobial peptide synthesised in the liver / C.H. Park, E.V. Valore, A.J. Waring, T. Ganz//J Biol Chem. - 2001. - 276 (11). - THE RIVER 7806-7810.

98. Hepcidin, the hormone of iron metabolism, is bound specifically to ALPHA-2 macroglobulin in blood / G. Peslova, J. Petrak, K. Kuzelova et al.//Blood. - 2009. - №113. - THE RIVER 6225-6236.

99. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin / T. Tanno, N.V. Bhanu, P.A. Oneal et al.//Nat Med. - 2007. - №13. - THE RIVER 1096-1101.

100. Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease / N. Maeno, S. Takei, Y. Nomura et al.//Arthritis Rheum. - 2002. - №46. - THE RIVER 2539-2541.

101. Hori, S. Control of regulatory T cell development by the transcription factor Foxp3 / S. Hori, T. Nomura, S. Sakaguchi//Science. - 2003. - №299. - THE RIVER 10571061.

102. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25 + regulatory T cells / E.A. Moseman X. Liang, A.J. Dawson et al.//Journal of Immunology. - 2004. - Vol.173, №7. - THE RIVER 4433-4442.

103. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis / S. Kotake, N. Udagawa, N. Takahashi et al.//J Clin Invest. - 1999. - №103. - THE RIVER 1345-1352.

104. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis / Y. Komiyama, S. Nakae, T. Matsuki et al.//J. Immunol. -

2006. - №177. - THE RIVER 566-573.

105. IL-17 stimulates the production and expression of proinflammatory cytokines, IL - 1в and TNF-a, by human macrophages / D.V. Jovanovic, J.A. Di Battista, J. Martel-Pelletier et al.//J Immunol. - 1998. - №160. - the River 3513-3521.

106. IL-6 - STAT-3 - hepcidin: linking inflammation to the iron metabolism I. Stoian, B. Manolescu V. Atanasiu et al.//Rom J Intern Med. - 2007. - 45 (3). - THE RIVER 305-309.

107. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin / E. Nemeth, S. Rivera V. Gabayan et al.//J Clin Invest. - 2004. - №113. - THE RIVER 1271-1276.

108. Il-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-TNF biologics: results from a 24-week multicentre randomised placebo controlled trial / P. Emery, E. Keystone, H.P. Tony et al.//Ann Rheum Dis. - 2008. - №67. - THE RIVER 1516-1523.

109. Immunoassay for human serum hepcidin / T. Ganz, G. Olbina, D. Girelli et al.//Blood. - 2008. - №112. - THE RIVER 4292-4297.

110. Immunologic tolerance maintained by CD25 + CD4 + regulatory T cells: their common role in controlling autoimmunity, tumour immunity, and transplantation tolerance / S. Sakaguchi, N. Sakaguchi, J. Shimizu et al.//Immunol Rev. - 2001. - №182. - THE RIVER 18-32.

111. Impaired skeletal development in interleukin-6-transgenic mice. A model for the impact of chronic inflammation on the growing skeletal system / F. De Benedetti, N. Rucci, A. Del Fattore et al.//Arthritis Rheum. - 2006. - №54. - THE RIVER 35513563.

112. Inappropriate expression of hepcidin is associated with iron refractory anaemia: implications for the anaemia of chronic disease / D.A. Weinstein, C.N. Roy, M.D. Fleming et al.//Blood. - 2002. - №100. - THE RIVER 3776-3781.

113. Increased expression of interleukin 17 in inflammatory bowel disease / S. Fujino, A. Andoh, S. Bamba et al.//Gut. - 2003. - №52. - THE RIVER 65-70.

114. Induction of hypoferremia and modulation of macrophage iron metabolism by tumour necrosis factor X. Alvarez-Hernandez, J. Liceaga, I.C. McKay, J.H. Brock / Lab Invest. - 1989. - №61. - THE RIVER 319-322.

115. Inflammation Regulates TMPRSS6 Expression via STAT5 / D. Meynard, C.C. Sun, Q. Wu et al.//PLoS One. - 2013. - 8 (12) - e82127. - 10р.

116. Inflammatory regulation of iron metabolism during thioacetamide-induced acute liver injury in rats / T. Izawa, H. Murakami, K.K. Wijesundera et al.//Exp Toxicol Pathol. - 2014. - 66 (2-3). - THE RIVER 155-162.

117. Influence of a recombinant human soluble tumour necrosis factor receptor Fc fusion protein on type II collagen-induced arthritis in mice / P.H. Wooley, J. Dutcher, M.B. Widmer, S. Gillis//J Immunol. - 1993. - №151. - THE RIVER 6602-6607.

118. Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression / J. Gao, J. Chen, M. Kramer et al.//Cell Metab. - 2009. - №9. P. 217-227.

119. Interferon gamma downregulates stem cell factor and erythropoietin receptors but not insulin-like growth factor-I receptors in human erythroid colony-forming cells / S. Taniguchi, C.H. Dai, J.O. Price, S.B. Krantz//Blood. - 1997. - №90. - THE RIVER 2244-2252.

120. Interleukin 10 co-operates with interleukin 4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells / E. Sugiyama, A. Kuroda, H. Taki et al.//J Rheumatol. - 1995. - №22. - THE RIVER 2020-2026.

121. Interleukin-17 / F. Fossiez, J. Banchereau, R. Murray et al.//Int Rev Immunol. - 1998. - №16. - THE RIVER 541-551.

122. Interleukin-17 family and IL-17 receptors / T.A. Moseley, D.R. Haudenschild, L. Rose, A.H. Reddi//Cytokine Growth Factor Rev. - 2003. - №14. - THE RIVER 155-174.

123. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis / J.S. Tzartos, M.A. Friese, M.J. Craner et al.//Am. J. Pathol. - 2008. - №172. - THE RIVER 146-155.

124. Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease / Y. Kawaguchi, H. Terajima, M. Harigai et al.//Arthritis Rheum. - 2001. - №44. - THE RIVER 1716-1717.

125. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation / S. Kotake, K. Sato, K.J. Kim et al.//J Bone Miner Res. - 1996. - №11. - THE RIVER 88-95.

126. Interleukin-6 biology is co-ordinated by membrane-bound and soluble receptors: role in inflammation and cancer / S. Rose-John, J. Scheller, G. Elson, Jones SA.//J Leukoc Biol. - 2006. - №80. - THE RIVER 227-236.

127. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with INAD - equate response to disease-modifying antirheumatic drugs / M.C. Genovese, J.D. McKay, E.L. Nasonov et al.//Arthritis Rheum. - 2008. - №58. - THE RIVER 2968-2980.

128. Intravenous iron optimises the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anaemia: a multicenter, open-label, randomized trial / M. Auerbach, H. Ballard, J.R. Trout et al.//J Clin Oncol. - 2004. - №22. - THE RIVER 1301-1307.

129. Iron refractory iron deficiency anaemia / L. De Falco, M. Sanchez, L. Silvestri et al.//Haematologica. - 2013. - 98 (6). - THE RIVER 845-853.

130. Iron release from human monocytes after erythrophagocytosis in vitro: an investigation in normal subjects and hereditary hemochromatosis patients / E. Moura, M.A. Noordermeer, N. Verhoeven et al.//Blood. - 1998. - №92. THE-RIVER 2511-2519.

131. Iron status and the outcome of HIV infection: an overview / V.R. Gordeuk, J.R. Delanghe, M.R. Langlois, J.R. Boelaert//J Clin Virol. - 2001. - №20. - THE RIVER 111115.

132. Iron storage indices: novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy / G.S. Teehan, D. Bahdouch, R. Ruthazer et al.//Clin Infect Dis. - 2004. - №38. - THE RIVER 1090-1094.

133. Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4 / L. Lin, E.V. Valore, E. Nemeth et al.//Blood. -

2007. - №110. - THE RIVER 2182-2189.

134. Jelkmann, W. Proinflammatory cytokines lowering erythropoietin production / W. Jelkmann//J Interferon Cytokine Res. - 1998. - №18. - THE RIVER 555-559.

135. Jones, G. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION Study / G. Jones, A. Sebba, J. Gu//Ann Rheum Dis. - 2010. - №69. - THE RIVER 88-96.

136. Juvenile idiopathic systemic arthritis / D. Baksiene, J. Kasparaviciene, M. Zebiene, B. Puteliene//Medicina (Kaunas). - 2003. - 39 (8). - THE RIVER 751-755.

137. Juvenile rheumatoid arthritis in affected sib-pairs / M.B. Moroldo, B.L. Tague, E.S. Shear et al.//Arthritis Rheum. - 1997. - №40. - THE RIVER 1962-1966.

138. Kanwar, P. Diagnosis and treatment of hereditary hemochromatosis: an update / P. Kanwar, K.V. Kowdley//Expert Rev Gastroenterol Hepatol. - 2013. - 7 (6). - THE RIVER 517-530.

139. Katz, Y. Interleukin-17 enhances tumour necrosis factor a-induced synthesis of interleukins 1, 6, and 8 in skin and synovial fibroblasts: a possible role as a “finetuning cytokine” in inflammation processes / Y. Katz, O. Nadiv, Y. Beer//Arthritis Rheum. - 2001. - №44. - the River 2176-2184.

140. Kletzmayr, J. High dose intravenous iron: a note of caution / J. Kletzmayr, G. Sunder-Plassmann, W.H. Horl//Nephrol Dial Transplant. - 2002. - №17. - THE RIVER 962-965.

141. Kolls, J.K. Interleukin-17 family members and inflammation / J.K. Kolls, A. Linden//Immunity. - 2004. - №21. - THE RIVER 467-476.

142. Kutukculer, N. Study of pro-inflammatory (TNF-a, IL-1a, IL-6) and T-T - derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: correlations with clinical and laboratory parametres / N. Kutukculer, S. Caglayan, F. Aydogdu//Clin Rheumatol. - 1998. - №17. - THE RIVER 288-292.

143. Lambing, A. The dangers of iron overload: bring in the iron police / A. Lambing, E. Kachalsky, M.L. Mueller//J Am Acad Nurse Pract. - 2012. - 24 (4). - THE RIVER 175-183.

144. Leirisalo-Repo, M. Early arthritis and infection / M. Leirisalo-Repo//Curr Opin Rheumatol. - 2005. - 17 (4). - THE RIVER 433-439.

145. Leitman, S.F. Hemochromatosis: the new blood donor / S.F. Leitman//Hematology Am Soc Hematol Educ Program. - 2013. - Vol. 2013, №1. - THE RIVER 645-650.

146. Lipschitz, D.A. A clinical evaluation of serum ferritin as an index of iron stores / D.A. Lipschitz, J.D. Cook, C.A. Finch//N Engl J Med. - 1974. - №290. - THE RIVER 1213-1216.

147. Liver iron modulates hepcidin expression during chronically elevated erythropoiesis in mice V. Diaz, E. Gammella, S. Recalcati et al.//Hepatology. - 2013. - 58 (6). - THE RIVER 2122-2132.

148. Locke, A. The copper and non-hemoglobinous iron contents of the blood serum in disease / A. Locke, E.R. Main, D.O. Rosbach//J. Clin. Invest. - 1932. - №11. - THE RIVER 527-542.

149. Masson, C. Rheumatoid anaemia / C. Masson//Joint Bone Spine. - 2011. - 78 (2). - THE RIVER 131-137.

150. Means, R.T. Jr. Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin / R.T. Jr Means, S.B. Krantz//Blood. - 1991. - №78. - THE RIVER 2564-2567.

151. Means, R.T. Jr. Recent developments in the anaemia of chronic disease / R.T. Jr Means//Curr Hematol Rep. - 2003. - №2. - THE RIVER 116-121.

152. Means, R.T. Pathogenesis of the anaemia of chronic disease: a cytokine-mediated anaemia / R.T. Means//Stem Cells. - 1995. - №13. - THE RIVER 32-37.

153. Michels-van Amelsfort, J.M. CD4+CD25 + regulatory T cells in systemic sclerosis and other rheumatic diseases / J.M. Michels-van Amelsfort, G.J. Walter, L.S. Taams//Expert Rev Clin Immunol. - 2011. - 7 (4). - THE RIVER 499-514.

154. Miyazawa, K. IL-6 synthesis by rheumatoid synoviocytes is autonomously upregulated at the transcriptional level / K. Miyazawa, A. Mori, H. Okudaira//J Allergy Clin Immunol. - 1999. - №103. - R S437-444.

155. Molnar-Kimber, K.L. Each type of cause that initiates rheumatoid arthritis or RA flares differentially affects the response to therapy / K.L. Molnar-Kimber, C.T. Kimber//Medical Hypotheses. - 2012. - №78. - THE RIVER 123-129.

156. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations / D. Foell, H. Wittkowski I. Hammerschmidt et al.//Arthritis Rheum. - 2004. - №50. - THE RIVER 1286-1295.

157. Murray, K. Pathogenesis of juvenile chronic arthritis: genetic and environmental factors / K. Murray, S.D. Thompson, D.N. Glass//Arch Dis Child. - 1997. - №77. - THE RIVER 530-534.

158. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis / G. Papanikolaou, M.E. Samuels, E.H. Ludwig et al.//Nat Genet. - 2004. - №36. - THE RIVER 77-82.

159. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation / T. Korn, J. Reddy, W. Gao et al.//Nat Med. - 2007. - №13. - THE RIVER 423-431.

160. Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells / D. Viemann, A. Strey, A. Janning et al.//Blood. - 2005. - №105. - THE RIVER 2955-2962.

161. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome / J. Villanueva, S. Lee, E.H. Giannini et al.//Arthritis Res Ther. - 2005. - №7. - R R30-37.

162. Nemeth, E. The role of hepcidin in iron metabolism / E. Nemeth, T. Ganz//Acta Haematol. - 2009. - 122 (2-3). - THE RIVER 78-86.

163. Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis / D.H. Lee, L.J. Zhou, Z. Zhou et al.//Blood. - 2010. - 115 (15). - THE RIVER 3136-3145.

164. Nepom, B.S. Juvenile rheumatoid arthritis and HLA: report of the Park City III workshop / B.S. Nepom, D.N. Glass//J Rheumatol Suppl. - 1992. - №33. - THE RIVER 70-74.

165. Niederkofler V. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload V. Niederkofler, R. Salie, S. Arber//J Clin Invest. - 2005. - №115. - THE RIVER 2180-2186.

166. Nishimoto, N. Interleukin 6: from bench to bedside / N. Nishimoto, T. Kishimoto//Nat Clin Pract Rheumatol. - 2006. - №2. - THE RIVER 619-626.

167. Nitric oxide suppression of human hematopoiesis in vitro: contribution to inhibitory action of interferon-gamma and tumour necrosis factor-alpha / J.P. Maciejewski, C. Selleri, T. Sato et al.//J Clin Invest. - 1995. - №96. - THE RIVER 10851092.

168. NKF-K/DOQI Clinical Practice Guidelines for anaemia of chronic kidney disease: update 2000//Am J Kidney Dis. - 2001. - №37, Suppl 1. - R S182-S238.

169. Oligoarticular juvenile idiopathic arthritis among Saudi children / M.M. Moued, H.M. Al-Saggaf, H.S. Habib, M.A. Muzaffer//Ann Saudi Med. - 2013. - 33 (6). - THE RIVER 529-532.

170. Oustamanolakis P, Koutroubakis IE, Kouroumalis EA. Diagnosing anaemia in inflammatory bowel disease: beyond the established markers / P. Oustamanolakis, I.E. Koutroubakis, E.A. Kouroumalis//J Crohns Colitis. - 2011. - 5 (5). - THE RIVER 381-91.

171. Pablos Alvarez, J.L. Interleukin 6 in the physiopathology of rheumatoid arthritis /

J.L.Pablos Alvarez//Reumatol Clin. - 2009. - 5 (1). - THE RIVER 34-39.

172. Pasare, C. Toll pathway-dependent blockade of CD4 + CD25 + T cell-mediated suppression by dendritic cells / C. Pasare, R. Medzhitov//Science. - 2003. - №299. - THE RIVER 1033-1036.

173. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease / K. Yoshizaki, T. Matsuda, N. Nishimoto et al.//Blood. - 1989. - №74. - THE RIVER 13601367.

174. Patterns of expression of tumour necrosis factor a, tumour necrosis factor in, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy / A.A. Grom, K.J. Murray, L. Luyrink et al.//Arthritis Rheum. - 1996. - №39. - the River 1703-1710.

175. Pettipher, E.R. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint / E.R. Pettipher, G.A. Higgs, B. Henderson//Proc Natl Acad Sci U S A. - 1986. - №83. - THE RIVER 8749-8753.

176. Phagocyte specific S100 proteins: a novel group of proinflammatory molecules /

J. Roth, T. Vogl, C. Sorg, C. Sunderkotter//Trends Immunol. - 2003. - №24. - THE RIVER 155-158.

177. Phelan, J. Genomic progress in pediatric arthritis: recent work and future goals / J. Phelan, S. Thompson//Curr Opin Rheumatol. - 2006. - №18. - THE RIVER 482-489.

178. Phenotypic and functional characterisation of CCR7 + and CCR7 - CD4 + memory T cells homing to the joints in juvenile idiopathic arthritis / M. Gattorno I. Prigione, F. Moranti et al.//Arthritis Res Ther. - 2005. - №7. - R R256-R267.

179. Pietrangelo, A. Physiology of iron transport and the hemochromatosis gene / A. Pietrangelo//Am J Physiol Gastrointest Liver Physiol. - 2002. - №282. - R G403-G414.

180. Polymorphichaplotypes of the interleukin-10 50 flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis / E. Crawley, R. Kay, J. Sillibourne et al.//Arthritis Rheum. - 1999. - №42. - THE RIVER 1101-1108.

181. Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction / R. Alvarez-Lafuente, B. Fernandez-Gutierrez, S. de Miguel et al.//Ann Rheum Dis. - 2005. - №64. - THE RIVER 1357-1359.

182. Prediction of response to erythropoietin treatment in chronic anaemia of cancer / H. Ludwig, E. Fritz, C. Leitgeb et al.//Blood. - 1994. - №84. - THE RIVER 1056-1063.

183. Prediction of response to iron sucrose in inflammatory bowel disease-associated anaemia / C. Gasche, T. Waldhoer, T. Feichtenschlager et al.//Am J Gastroenterol. - 2001. - №96. - THE RIVER 2382-2387.

184. Prevalence and causes of anaemia in elderly hospitalised patients / Y. Matzner, S. Levy, N. Grossowicz et al.//Gerontology. - 1979. - №25. - THE RIVER 113-119.

185. Prevalence and outcome of anaemia in rheumatoid arthritis: a systematic review of the literature / A. Wilson, H.T. Yu, L.T. Goodnough, A.R. Nissenson//Am J Med. - 2004. - №116, Suppl.7A. - THE RIVER 50S-57S.

186. Prevalence of anaemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anaemia / J.M. Guralnik, R.S. Eisenstaedt, L. Ferucci et al.//Blood. - 2004. - №104. - THE RIVER 2263-2268.

187. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4 / J.A.G. van Roon, J.L.A.M. van Roy, F.H.J. Gmelig-Meyling et al.//Arthritis Rheum. - 1996. - №39. - THE RIVER 829-835.

188. Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4 / J.A.G. van Roon, J.L.A.M. van Roy, A. Duits et al.//Ann Rheum Dis. - 1995. - №54. - THE RIVER 836840.

189. Punnonen, K. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency / K. Punnonen, K. Irjala, A. Rajamaki//Blood. - 1997. - №89. - THE RIVER 1052-1057.

190. Quantitative assessment of erythropoiesis and functional classification of anaemia based on measurements of serum transferrin receptor and erythropoietin / Y. Beguin, G.K. Clemons, P. Pootrakul, G. Fillet//Blood. - 1993. - №81. - THE RIVER 1067-1076.

191. Raj, D.S. Role of interleukin-6 in the anaemia of chronic disease / D.S. Raj//Semin Arthritis Rheum. - 2009. - №38. - THE RIVER 382-388.

192. Ravelli, A. Juvenile idiopathic arthritis / A. Ravelli, A. Martini / Lancet. - 2007. - №369. - THE RIVER 767-778.

193. Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease; utility measures correlate strongly with disease activity measures / H.R. Peeters, M. Jongen-Lavrencic, C.H. Bakker et al.//Rheumatol Int. - 1999. - 18 (5-6). - THE RIVER 201-206.

194. Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation / N.M. Wulffraat, G.T. Rijkers, E. Elst et al.//Rheumatology. - 2003. - №42. - THE RIVER 375-379.

195. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs) / C. Peyssonnaux, A.S. Zinkernagel, R.A. Schuepbach et al.//J Clin Invest. - 2007. - №117. - THE RIVER 1926-1932.

196. Role of hepcidin in murine brain iron metabolism / S.M. Wang, L.J. Fu, X.L. Duan et al.//Cell Mol Life Sci. - 2010. - 67 (1). - THE RIVER 123-33.

197. Role of IL-10 for induction of anaemia during inflammation / H. Tilg, H. Ulmer, A. Kaser, G. Weiss//J Immunol. - 2002. - №169. - THE RIVER 2204-2209.

198. Role of interleukin (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade V. Pascual, F. Allantaz, E. Arce et al.//J Exp Med. - 2005. - №201. - THE RIVER 1479-1486.

199. Rosen, P. Non-HLA gene polymorphisms in juvenile rheumatoid arthritis / P. Rosen, S. Thompson, D. Glass//Clin Exp Rheumatol. - 2003. - №21. - THE RIVER 650656.

200. Selective recruitment of polarised T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis / L.R. Wedderburn, N. Robinson, A. Patel et al.//Arthritis Rheum. - 2000. - №43. - THE RIVER 765-774.

201. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parametres and clinical subtypes / H. Mangge, H. Kenzian, S. Gallistl et al.//Arthritis Rheum. - 1995. - №38. - THE RIVER 211-220.

202. Serum hepcidin: reference ranges and biochemical correlates in the general population / T.E. Galesloot, S.H. Vermeulen, A.J. Geurts-Moespot et al.//Blood.

- 2011. - 117 (25). - THE RIVER 218-225.

203. Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis / F. De Benedetti, M. Massa, P. Pignatti et al.//J Clin Invest. - 1994. - №93. - THE RIVER 2114-2119.

204. Severe iron deficiency anaemia in transgenic mice expressing liver hepcidin / G. Nicolas, M. Bennoun, A. Porteu et al.//Proc Natl Acad Sci USA. - 2002. - №99. - THE RIVER 4596-4601.

205. Shander, A. Iron overload and toxicity: the hidden risk of multiple blood transfusions / A. Shander, M.D. Cappellini, L.T. Goodnough / Vox Sang. - 2009.

- 97 (3). - THE RIVER 185-197.

206. Specificity of T cells in synovial fluid: high frequencies of CD8 (+) T cells that are specific for certain viral epitopes / L.C. Tan, A.G. Mowat, C. Fazou et al.//Arthritis Res. - 2000. - №2. - THE RIVER 154-164.

207. Spivak, J.L. Iron and the anaemia of chronic disease / JL. Spivak//Oncology (Huntingt). - 2002. - №16, Suppl 10. - THE RIVER 25-33.

208. Sugino, H. DNA microarray analysis of rheumatoid arthritis susceptibility genes identified by genome-wide association studies / H. Sugino, H.M. Lee, N. Nishimoto//Arthritis Res Ther. - 2010. - №12. - THE RIVER 401.

209. Sullivan, J.L. Iron therapy and cardiovascular disease / J.L. Sullivan//Kidney Int Suppl. - 1999. - №69. - R S135-S137.

210. Suppression of hepcidin during anaemia requires erythropoietic activity / M. Pak,

M.A. Lopez V. Gabayan et al.//Blood. - 2006. - №108. - THE RIVER 3730-3735.

211. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice / S. Nakae, A. Nambu, K. Sudo, Y. Iwakura//J Immunol. - 2003. - №171. - THE RIVER 6173-6177.

212. Synovial expression of osteopontin correlates with angiogenesis in juvenile idiopathic arthritis / M. Gattorno, A. Gregorio, F. Ferlito et al.//Rheumatology. - 2004. - №43. - THE RIVER 1091-1096.

213. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs / S. Rivera, E. Nemeth V. Gabayan et al.//Blood. - 2005. - №106. - THE RIVER 2196-2199.

214. Tang, Q. The Foxp3 + regulatory T cell: a jack of all trades, master of regulation / Q. Tang, JA. Bluestone//Nat Immunol. - 2008. - 9 (3). - THE RIVER 239-244.

215. Th17 functions as an osteoclastogenic helper T cells subset that links T cell activation and bone destruction / K. Sato, A. Suematsu, K. Okamoto et al.//J Exp Med. - 2006. - №203. - THE RIVER 2673-2682.

216. Th17: an effector of CD4 T cell lineage with regulatory T cell ties / C.T. Weaver, L.E. Harrington, P.R. Mangan et al.//Immunity. - 2006. - №24. - THE RIVER 677-688.

217. The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells / M. Shingu, Y. Nagai, T. Isayama et al.//Clin Exp Immunol. - 1993. - №94. - THE RIVER 145-149.

218. The gene encoding the iron regulatory peptide hepcidin is regulated by anaemia, hypoxia, and inflammation / G. Nicolas, C. Chauvet, L. Viatte et al.//J Clin Invest. - 2002. - 110 (7). - THE RIVER 1037-1044.

219. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 / C.L. Bennett, J. Christie, F. Ramsdell et al.//Nat Genet. - 2001. - №27. - THE RIVER 20-21.

220. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis / A. Donovan, C.A. Lima, J.L. Pinkus et al.//Cell Metab. - 2005. - №1. - THE RIVER 191200.

221. The iron-regulatory peptide hormone hepcidin: expression and cellular localisation in the mammalian kidney / H. Kulaksiz, F. Theilig, S. Bachmann et al.//J Endocrinol. - 2005. - №184. - THE RIVER 361-370.

222. The molecular basis of hepcidin-resistant hereditary hemochromatosis / A. Fernandes, G.C. Preza, Y. Phung et al.//Blood. - 2009. - №114. - THE RIVER 437-443.

223. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study / E. Nemeth, G.C. Preza, C.L. Jung et al.//Blood. - 2006. - №107. - THE RIVER 328-333.

224. Therapeutic efficacy of humanised recombinant anti-interleukin-6 receptor antibody in children with systemic onset juvenile idiopathic arthritis / S. Yokota, T. Miyamae, T. Imagawa et al.//Arthritis Rheum. - 2005. - №52. - THE RIVER 818-825.

225. Torti, F.M. Regulation of ferritin genes and protein / F.M. Torti, SV. Torti//Blood. - 2002. - №99. - THE RIVER 3505-3516.

226. Transferrin receptor 2: evidence for ligand-induced stabilisation and redirection to a recycling pathway / M.B. Johnson, J. Chen, N. Murchison et al.//Mol Biol Cell. - 2007. - №18. - THE RIVER 743-754.

227. Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with v-thalassemia major: a longitudinal study / S.R. Pasricha, D.M. Frazer, D.K. Bowden, G.J. Anderson//Blood. - 2013. - 122 (1). - the River 124-133.

228. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis / J. Keffer, L. Probert, H. Cazlaris et al.//EMBO J. - 1991. - №10. - THE RIVER 4025-4031.

229. Treatment with a neutralising anti-murine IL-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction and bone erosion / E. Lubberts, M.I. Konders, B. Oppers-Walgreen et al.//Arthritis Rheum. - 2004. - №50. - THE RIVER 650-659.

230. Treatment with infliximab plus methotrexate improves anaemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures - a pooled analysis from three large, multicenter, double-blind, randomized clinical trials / M.K. Doyle, M.U. Rahman, C. Han et al.//Semin Arthritis Rheum. - 2008. - №39. - THE RIVER 123-131.

231. Tubular reabsorption and local production of urine hepcidin-25 / H.P. Peters, C.M. Laarakkers, P. Pickkers et al.//BMC Nephrol. - 2013. - №14. - THE RIVER 70.

232. Two components contributing to reduced treg surface CD25 in sle patients and their unaffected relatives / N. Costa, O. Marques, S. Godinho et al.//Ann Rheum Dis. - 2014. - №73, Suppl 1. - R A44.

233. Uchiyama, Y. Anemia in monkey collagen-induced arthritis is correlated with serum IL-6, but not TNFalpha / Y. Uchiyama, N. Koike, M. Mihara//Rheumatol Int. - 2008. - 28 (9). - THE RIVER 879-883.

234. Use of agents stimulating erythropoiesis in digestive diseases / R. Moreno Lopez, B. Sicilia Aladren, F. Gomollon Garcia//World J Gastroenterol. - 2009. - №15. - THE RIVER 4675-4685.

235. Use of epoetin in patients with cancer: EVIDENCE - based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology / J.D. Rizzo, A.E. Lichtin, S.H. Woolf et al.//J Clin Oncol. - 2002. - №20. - THE RIVER 4083-4107.

236. Validity and predictive ability of the juvenile arthritis disease activity score based on CRP versus ESR in a Nordic population-based setting / E.B. Nordal, M. Zak,

K. Aalto et al.//Ann Rheum Dis. - 2012. - №71. - P. 1122-1127.

237. Valore, E.V. Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin / E.V. Valore, T. Ganz//Blood Cells Mol Dis. - 2008. - №40. - THE RIVER 132-138.

238. Vamvakas, E.C. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? / E.C. Vamvakas, M.A. Blajchman / Blood. - 2001. - №97. - THE RIVER 1180-1195.

239. Villarroel, P. Interleukin-6 and lipopolysaccharide modulate hepcidin mRNA expression by HepG2 cells / P. Villarroel, S. Le Blanc, M. Arredondo//Biol Trace Elem Res. - 2012. - 150 (1-3). - THE RIVER 496-501.

240. Vyoral, D. Hepcidin: a direct link between iron metabolism and immunity / D. Vyoral, J. Petrak//Int J Biochem Cell Biol. - 2005. - 37 (9). - THE RIVER 1768-1773.

241. Wang, C.Q. INTERFERON - gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development / C.Q. Wang,

K.B. Udupa, D.A. Lipschitz//J Cell Physiol. - 1995. - №162. - THE RIVER 134-138.

242. Ware, H.M. Evaluation and treatment of transfusional iron overload in children / H.M. Ware, J.L. Kwiatkowski//Pediatr Clin North Am. - 2013. - 60 (6). - THE RIVER 1393-1406.

243. Weinberg, E.D. Iron loading and disease surveillance / E.D. Weinberg//Emerg Infect Dis. - 1999. - №5. - THE RIVER 346-352.

244. Weiss, G. Anaemia in inflammatory rheumatic diseases / G. Weiss, G. Schett//Nat Rev Rheumatol. - 2013. - 9 (4). - THE RIVER 205-215.

245. Weiss, G. Anemia of chronic disease / G. Weiss, L.T. Goodnough//N Engl J Med. - 2005. - 352 (10). - THE RIVER 1011-1023.

246. Weiss, G. Iron and immunity: a double-edged sword / G. Weiss//Eur J Clin Invest. - 2002. - №32, Suppl 1. - THE RIVER 70-78.

247. Weiss, G. Iron metabolism in the anaemia of chronic disease / G. Weiss//Biochim Biophys Acta. - 2009. - 1790 (7). - THE RIVER 682-693.

248. Weiss, G. Pathogenesis and treatment of anaemia of chronic disease / G. Weiss//Blood Rev. - 2002. - 16 (2). - THE RIVER 87-96.

249. Williams, R.O. Anti-tumour necrosis factor ameliorates joint disease in murine collagen-induced arthritis / R.O. Williams, M. Feldmann, R.N. Maini//Proc Natl Acad Sci U S A. - 1992. - №89. - THE RIVER 9784-9788.

250. Wing, K. Regulatory T cells exert checks and balances on self tolerance and autoimmunity / K. Wing, S. Sakaguchi//Nat. Immunol. - 2010. - №11. - R 713.

251. Winn, R.J. The NCCN guidelines development process and infrastructure / R.J. Winn//Oncology (Huntingt). - 2000. - №14. - THE RIVER 26-30.

252. Yap, G.S. Inhibition of in vitro erythropoiesis by soluble mediators in Plasmodium chabaudi AS malaria: lack of a major role for interleukin 1, tumour necrosis factor alpha, and gamma interferon / G.S. Yap, M.M. Stevenson//Infect Immun. - 1994. - №62. - THE RIVER 357-362.

253. Zechel, S. Distribution of the iron-regulating protein hepcidin in the murine central nervous system / S. Zechel, K. Huber-Wittmer, O. von Bohlen Halbach//J Neurosci Res. - 2006. - 84 (4). - THE RIVER 790-800.

254. Zhang X. Beyond anaemia: hepcidin, monocytes and inflammation X. Zhang, B.H. Rovin//Biol Chem. - 2013. - 394 (2). - THE RIVER 1-10.

255. Zhang X. Hepcidin expression by human monocytes in response to adhesion and pro-inflammatory cytokines X. Zhang, B.H. Rovin//Biochim Biophys Acta. - 2010. - №1800. - THE RIVER 1262-1267.

256. Zhao, N. Iron regulation by hepcidin / N. Zhao, A.S. Zhang, C.A. Enns//J Clin Invest. - 2013. - 123 (6). - THE RIVER 2337-2343.

<< |
Scientific source EGOROV Andrey Sergeevich. THE GEPSIDIN-INTERLEUKIN-6 SYSTEM AS A FACTOR FOR MANAGING THE COURSE OF ANEMIA IN CHRONIC ARTHRITIS IN CHILDREN DISSERTATION for the degree of candidate of medical sciences. St. Petersburg - 2016. 2016

Other medical related information THE LITERATURE LIST:

  1. THE LITERATURE LIST
  2. THE LITERATURE LIST
  3. THE LITERATURE LIST
  4. THE LITERATURE LIST
  5. THE LITERATURE LIST
  6. THE LITERATURE LIST
  7. THE LITERATURE LIST
  8. the literature List
  9. THE LITERATURE LIST
  10. THE LITERATURE LIST
  11. THE LITERATURE LIST
  12. the literature List
  13. THE LITERATURE LIST
  14. THE LITERATURE LIST
  15. THE LITERATURE LIST:
  16. THE LITERATURE LIST
  17. THE LITERATURE LIST.
  18. THE LITERATURE LIST
  19. THE LITERATURE LIST:
  20. THE LITERATURE LIST: